Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fee

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 30, 2010
Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotypeJoelle M-J Romac, Masaki Ohmuraya, Cathy Bittner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinomaQuynh-Thu Le, David Tate, Albert Koong, et al.
Cancer|March 15, 2006
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasQuynh-Thu Le, Al Taira, Sherie Budenz, et al.
Journal of Leukocyte Biology|November 20, 2025
Differential roles for Irgm1 in myeloid cells for immune resistance to pathogenic bacteriaBrian E Fee, Lanette R Fee, Aemilia R Sprouse, et al.
The Laryngoscope|August 1, 1997
Hypopharyngeal cancer patient care evaluationH T Hoffman, L H Karnell, J P Shah, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinomaWendy Hara, Billy W Loo, Don R Goffinet, et al.
Molecular Cancer Therapeutics|September 4, 2007
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasionAnita B Hjelmeland, Kathryn P Lattimore, Brian E Fee, et al.
Respiratory Research|November 20, 2020
Treatment-related biomarkers in pulmonary hypertension patients on oral therapiesAparna C Swaminathan, Hongmei Zhu, Victor Tapson, et al.
CNS Neuroscience & Therapeutics|February 4, 2014
AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganizationLei Han, Kai-Liang Zhang, Jun-Xia Zhang, et al.
Disease Models & Mechanisms|January 24, 2018
Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient miceAllison R Rogala, Alexi A Schoenborn, Brian E Fee, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 30, 2010
Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotypeJoelle M-J Romac, Masaki Ohmuraya, Cathy Bittner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinomaQuynh-Thu Le, David Tate, Albert Koong, et al.
Cancer|March 15, 2006
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomasQuynh-Thu Le, Al Taira, Sherie Budenz, et al.
Journal of Leukocyte Biology|November 20, 2025
Differential roles for Irgm1 in myeloid cells for immune resistance to pathogenic bacteriaBrian E Fee, Lanette R Fee, Aemilia R Sprouse, et al.
The Laryngoscope|August 1, 1997
Hypopharyngeal cancer patient care evaluationH T Hoffman, L H Karnell, J P Shah, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinomaWendy Hara, Billy W Loo, Don R Goffinet, et al.
Molecular Cancer Therapeutics|September 4, 2007
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasionAnita B Hjelmeland, Kathryn P Lattimore, Brian E Fee, et al.
Respiratory Research|November 20, 2020
Treatment-related biomarkers in pulmonary hypertension patients on oral therapiesAparna C Swaminathan, Hongmei Zhu, Victor Tapson, et al.
CNS Neuroscience & Therapeutics|February 4, 2014
AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganizationLei Han, Kai-Liang Zhang, Jun-Xia Zhang, et al.
Disease Models & Mechanisms|January 24, 2018
Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient miceAllison R Rogala, Alexi A Schoenborn, Brian E Fee, et al.
Pageof 16